The global market for Neonatal Respiratory Distress Syndrome Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neonatal Respiratory Distress Syndrome Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Neonatal Respiratory Distress Syndrome Treatment by region & country, by Type, and by Application.

The Neonatal Respiratory Distress Syndrome Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neonatal Respiratory Distress Syndrome Treatment.

Market Segmentation

Scope of Neonatal Respiratory Distress Syndrome Treatment - Market Report

Report Metric	Details
Report Name	Neonatal Respiratory Distress Syndrome Treatment - Market
CAGR	5%
Segment by Type:	Oxygen Therapy Surfactant Therapy Others
Segment by Application	Hospitals Home Care Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic, Dragerwerk, GE HealthCare, Koninklijke Philips, Smiths Medical, Fisher & Paykel Healthcare, IBIO, Windtree Therapeutics, Synthetic Biologics, Synairgen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neonatal Respiratory Distress Syndrome Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Neonatal Respiratory Distress Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Neonatal Respiratory Distress Syndrome Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Neonatal Respiratory Distress Syndrome Treatment - Market report?

Ans: The main players in the Neonatal Respiratory Distress Syndrome Treatment - Market are Medtronic, Dragerwerk, GE HealthCare, Koninklijke Philips, Smiths Medical, Fisher & Paykel Healthcare, IBIO, Windtree Therapeutics, Synthetic Biologics, Synairgen

What are the Application segmentation covered in the Neonatal Respiratory Distress Syndrome Treatment - Market report?

Ans: The Applications covered in the Neonatal Respiratory Distress Syndrome Treatment - Market report are Hospitals, Home Care, Others

What are the Type segmentation covered in the Neonatal Respiratory Distress Syndrome Treatment - Market report?

Ans: The Types covered in the Neonatal Respiratory Distress Syndrome Treatment - Market report are Oxygen Therapy, Surfactant Therapy, Others

1 Market Overview

1.1 Neonatal Respiratory Distress Syndrome Treatment Product Introduction

1.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size Forecast

1.3 Neonatal Respiratory Distress Syndrome Treatment Market Trends & Drivers

1.3.1 Neonatal Respiratory Distress Syndrome Treatment Industry Trends

1.3.2 Neonatal Respiratory Distress Syndrome Treatment Market Drivers & Opportunity

1.3.3 Neonatal Respiratory Distress Syndrome Treatment Market Challenges

1.3.4 Neonatal Respiratory Distress Syndrome Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Neonatal Respiratory Distress Syndrome Treatment Players Revenue Ranking (2023)

2.2 Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Company (2019-2024)

2.3 Key Companies Neonatal Respiratory Distress Syndrome Treatment Manufacturing Base Distribution and Headquarters

2.4 Key Companies Neonatal Respiratory Distress Syndrome Treatment Product Offered

2.5 Key Companies Time to Begin Mass Production of Neonatal Respiratory Distress Syndrome Treatment

2.6 Neonatal Respiratory Distress Syndrome Treatment Market Competitive Analysis

2.6.1 Neonatal Respiratory Distress Syndrome Treatment Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Neonatal Respiratory Distress Syndrome Treatment Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Respiratory Distress Syndrome Treatment as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oxygen Therapy

3.1.2 Surfactant Therapy

3.1.3 Others

3.2 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type

3.2.1 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Home Care

4.1.3 Others

4.2 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application

4.2.1 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region

5.1.1 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region (2019-2024)

5.1.3 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region (2025-2030)

5.1.4 Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

5.2.2 North America Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

5.3.2 Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

5.4.2 Asia Pacific Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

5.5.2 South America Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

5.6.2 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Neonatal Respiratory Distress Syndrome Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Neonatal Respiratory Distress Syndrome Treatment Sales Value

6.3 United States

6.3.1 United States Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

6.3.2 United States Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

6.4.2 Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

6.5.2 China Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

6.6.2 Japan Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

6.7.2 South Korea Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019-2030

6.9.2 India Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Medtronic

7.1.1 Medtronic Profile

7.1.2 Medtronic Main Business

7.1.3 Medtronic Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.1.4 Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.1.5 Medtronic Recent Developments

7.2 Dragerwerk

7.2.1 Dragerwerk Profile

7.2.2 Dragerwerk Main Business

7.2.3 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.2.4 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.2.5 Dragerwerk Recent Developments

7.3 GE HealthCare

7.3.1 GE HealthCare Profile

7.3.2 GE HealthCare Main Business

7.3.3 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.3.4 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.3.5 Koninklijke Philips Recent Developments

7.4 Koninklijke Philips

7.4.1 Koninklijke Philips Profile

7.4.2 Koninklijke Philips Main Business

7.4.3 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.4.4 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.4.5 Koninklijke Philips Recent Developments

7.5 Smiths Medical

7.5.1 Smiths Medical Profile

7.5.2 Smiths Medical Main Business

7.5.3 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.5.4 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.5.5 Smiths Medical Recent Developments

7.6 Fisher & Paykel Healthcare

7.6.1 Fisher & Paykel Healthcare Profile

7.6.2 Fisher & Paykel Healthcare Main Business

7.6.3 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.6.4 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.6.5 Fisher & Paykel Healthcare Recent Developments

7.7 IBIO

7.7.1 IBIO Profile

7.7.2 IBIO Main Business

7.7.3 IBIO Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.7.4 IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.7.5 IBIO Recent Developments

7.8 Windtree Therapeutics

7.8.1 Windtree Therapeutics Profile

7.8.2 Windtree Therapeutics Main Business

7.8.3 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.8.4 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.8.5 Windtree Therapeutics Recent Developments

7.9 Synthetic Biologics

7.9.1 Synthetic Biologics Profile

7.9.2 Synthetic Biologics Main Business

7.9.3 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.9.4 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.9.5 Synthetic Biologics Recent Developments

7.10 Synairgen

7.10.1 Synairgen Profile

7.10.2 Synairgen Main Business

7.10.3 Synairgen Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

7.10.4 Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue (US$ Million) & (2019-2024)

7.10.5 Synairgen Recent Developments

8 Industry Chain Analysis

8.1 Neonatal Respiratory Distress Syndrome Treatment Industrial Chain

8.2 Neonatal Respiratory Distress Syndrome Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Neonatal Respiratory Distress Syndrome Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Neonatal Respiratory Distress Syndrome Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Fisher & Paykel Healthcare

IBio Inc.

Windtree Therapeutics

Synthetic Biologics

Synairgen

List of Tables

Table 1. Neonatal Respiratory Distress Syndrome Treatment Market Trends

Table 2. Neonatal Respiratory Distress Syndrome Treatment Market Drivers & Opportunity

Table 3. Neonatal Respiratory Distress Syndrome Treatment Market Challenges

Table 4. Neonatal Respiratory Distress Syndrome Treatment Market Restraints

Table 5. Global Neonatal Respiratory Distress Syndrome Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Neonatal Respiratory Distress Syndrome Treatment Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Neonatal Respiratory Distress Syndrome Treatment Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Neonatal Respiratory Distress Syndrome Treatment Product Type

Table 9. Key Companies Time to Begin Mass Production of Neonatal Respiratory Distress Syndrome Treatment

Table 10. Global Neonatal Respiratory Distress Syndrome Treatment Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Respiratory Distress Syndrome Treatment as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Neonatal Respiratory Distress Syndrome Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Neonatal Respiratory Distress Syndrome Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Neonatal Respiratory Distress Syndrome Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Neonatal Respiratory Distress Syndrome Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region (2019-2024) & (%)

Table 27. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Neonatal Respiratory Distress Syndrome Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2025-2030) & (US$ Million)

Table 31. Medtronic Basic Information List

Table 32. Medtronic Description and Business Overview

Table 33. Medtronic Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 34. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of Medtronic (2019-2024)

Table 35. Medtronic Recent Developments

Table 36. Dragerwerk Basic Information List

Table 37. Dragerwerk Description and Business Overview

Table 38. Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 39. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of Dragerwerk (2019-2024)

Table 40. Dragerwerk Recent Developments

Table 41. GE HealthCare Basic Information List

Table 42. GE HealthCare Description and Business Overview

Table 43. GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 44. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of GE HealthCare (2019-2024)

Table 45. GE HealthCare Recent Developments

Table 46. Koninklijke Philips Basic Information List

Table 47. Koninklijke Philips Description and Business Overview

Table 48. Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 49. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of Koninklijke Philips (2019-2024)

Table 50. Koninklijke Philips Recent Developments

Table 51. Smiths Medical Basic Information List

Table 52. Smiths Medical Description and Business Overview

Table 53. Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 54. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of Smiths Medical (2019-2024)

Table 55. Smiths Medical Recent Developments

Table 56. Fisher & Paykel Healthcare Basic Information List

Table 57. Fisher & Paykel Healthcare Description and Business Overview

Table 58. Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 59. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of Fisher & Paykel Healthcare (2019-2024)

Table 60. Fisher & Paykel Healthcare Recent Developments

Table 61. IBIO Basic Information List

Table 62. IBIO Description and Business Overview

Table 63. IBIO Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 64. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of IBIO (2019-2024)

Table 65. IBIO Recent Developments

Table 66. Windtree Therapeutics Basic Information List

Table 67. Windtree Therapeutics Description and Business Overview

Table 68. Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 69. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of Windtree Therapeutics (2019-2024)

Table 70. Windtree Therapeutics Recent Developments

Table 71. Synthetic Biologics Basic Information List

Table 72. Synthetic Biologics Description and Business Overview

Table 73. Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 74. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of Synthetic Biologics (2019-2024)

Table 75. Synthetic Biologics Recent Developments

Table 76. Synairgen Basic Information List

Table 77. Synairgen Description and Business Overview

Table 78. Synairgen Neonatal Respiratory Distress Syndrome Treatment Products, Services and Solutions

Table 79. Revenue (US$ Million) in Neonatal Respiratory Distress Syndrome Treatment Business of Synairgen (2019-2024)

Table 80. Synairgen Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Neonatal Respiratory Distress Syndrome Treatment Downstream Customers

Table 84. Neonatal Respiratory Distress Syndrome Treatment Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Neonatal Respiratory Distress Syndrome Treatment Product Picture

Figure 2. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Neonatal Respiratory Distress Syndrome Treatment Report Years Considered

Figure 5. Global Neonatal Respiratory Distress Syndrome Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Neonatal Respiratory Distress Syndrome Treatment Revenue in 2023

Figure 7. Neonatal Respiratory Distress Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Oxygen Therapy Picture

Figure 9. Surfactant Therapy Picture

Figure 10. Others Picture

Figure 11. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Hospitals

Figure 14. Product Picture of Home Care

Figure 15. Product Picture of Others

Figure 16. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Neonatal Respiratory Distress Syndrome Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Neonatal Respiratory Distress Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Neonatal Respiratory Distress Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Neonatal Respiratory Distress Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Neonatal Respiratory Distress Syndrome Treatment Sales Value (%), (2019-2030)

Figure 29. United States Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 35. China Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 37. China Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 47. India Neonatal Respiratory Distress Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Neonatal Respiratory Distress Syndrome Treatment Sales Value by Type (%), 2023 VS 2030

Figure 49. India Neonatal Respiratory Distress Syndrome Treatment Sales Value by Application (%), 2023 VS 2030

Figure 50. Neonatal Respiratory Distress Syndrome Treatment Industrial Chain

Figure 51. Neonatal Respiratory Distress Syndrome Treatment Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4Q13596

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Lysosomal Acid Lipase Deficiency Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6I13272

Sat Oct 05 00:00:00 UTC 2024

Add to Cart

Neonatal Respiratory Distress Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-0L13961

Sat Oct 05 00:00:00 UTC 2024

Add to Cart

Phenylketonuria Treatment Product - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-34D5897

Tue Oct 01 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Neonatal Respiratory Distress Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-0L13961

Neonatal Respiratory Distress Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Neonatal Respiratory Distress Syndrome Treatment - Market Size

Neonatal Respiratory Distress Syndrome Treatment - Market

Report Scope

Scope of Neonatal Respiratory Distress Syndrome Treatment - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Neonatal Respiratory Distress Syndrome Treatment - Market report?

What are the Application segmentation covered in the Neonatal Respiratory Distress Syndrome Treatment - Market report?

What are the Type segmentation covered in the Neonatal Respiratory Distress Syndrome Treatment - Market report?

FEATURED COMPANIES

RELATED REPORTS